Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Centre for Genomic Regulation
Other

Centre for Genomic Regulation

Tracked across 1 events · 6 articles · First seen Jun 10, 2026 · Last active Jun 10, 2026

Sentiment
15
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 15
Tech
CONNECTA_Therapeutics Initiates CTH120 Phase IIa Trial
CONNECTA Therapeutics>>>, a clinical-stage biotech company, announced the initiation of its Phase IIa clinical trial for CTH120, a first-in-class neuroplasticity modulator, in adult males with Fragile X syndrome>>>. This study builds on positive Phase I…
Impact: Centre for Genomic Regulation>>> will contribute to advancing the identification of disease-specific biomarkers for Fragile X syndrome>>> in conjunction with the clinical trial.
Jun 10, 2026 · 6 articles
NEWSDESK
Track Centre for Genomic Regulation live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.